In pandemic Heart failure in the general population has evolved in recent years while affecting old age.

This is because 30-40% of patients in the general population, with advanced heart failure, die in the first year from their admission to the hospital, while over 10% of older people suffer from heart failure.

The mortality of patients with heart failure, according to statistics, is greater than the most severe forms of cancer. An element that proves that heart failure in recent years has been “competing” with cancer.

“The spread of the disease in recent years, mainly in old age, has taken the form of a pandemic as it affects more than 65 million people worldwide.” The president of the Society for the Study and Research of Heart Failure (EMKA), Professor of Cardiology/ Emergency Medicine, I. Paris, on the occasion of the 26th Panhellenic Congress of Cardiac Failure, which begins January 31 at the Divani Hotel, at the Divani Hotel.

The rapid increase in heart failure, in addition to serious illness for sufferers, is an open wound for the national health system, As 600-700 hospital beds are permanently occupied by her patients.

Given that the population over 65 is increasing each year, the number of heart failure patients in Greece is expected to exceed 20,000 to 25,000 in the near future.

As a result, the number of patients in need in addition to medication and more specialized, but also more expensive treatments (such as amphitheater pacing, defibrillators, heart transplantation and mechanical support with “artificial” heart). to increase respectively.

So the most important developments related to the complex heart failure syndrome from which thousands of people have in our country will be presented at the 26th Panhellenic Congress of Heart Failure at the three -day Panhellenic Congress.

Specifically, the conference will cover issues that concern every health professional facing patients with heart failure, including established therapeutic approaches and newer clinical and research data. The delegates will additionally be able to find out about the newer developments in cardio-oncology, an ever-increasing problem that accompanies modern effective cancer treatments. At the same time, the importance of the Pan-Hellenic Surprise of Heart Failure and Cardi-Engology, the beneficial role of physical activity programs will be demonstrated with the excellent cooperation of the Elega (Hellenic Society treatments applied to patients with heart failure.

In addition, EMKA’s long -standing cooperation with the European Society of Heart Failure (HFA) and the Hellenic Cardiology Society will enable the delegates to attend joint events with particularly up -to -date issues for the treatment of the syndrome.

Finally, the conference will also meet the National Heart Failure Network and the National Cardi-Oncology Practice Network, where a wide range of issues will be covered. Experts’ collaboration is essential to better treat patients with heart failure. The network of 75 clinics, one of the first networks developed worldwide, will discuss the conditions for better cooperation, for the benefit of patients.

“After 28 years of successful course of EMKA, the conference provides specialized knowledge to participants and is a field for a wider scientific and social dialogue focusing on heart failure” Professor Paris concludes, saying: “We invite all healthcare professionals who face daily patients with heart failure, to embrace our efforts and to actively participate in the work of our conference in an interactive way, enriching and renewing their knowledge, exchanging views, and ultimately, participating in the landscape. of heart failure in our country. “

The participating doctors provide 23 European molecules of continuing ECMECS medical education by EACCME. Those who wish to attend the conference have the right to participate without any costs of registration.